After more than 60 years of waiting, 2026 will finally bring men new contraceptive options beyond condoms and vasectomy. Plan A, a reversible injectable contraceptive, is expected to launch to the public, while hormonal gels completing Phase 2 trials show 86% effectiveness. Meanwhile, artificial intelligence is revolutionizing IVF with embryo selection algorithms that predict success with "surprising accuracy," potentially breaking through the decades-long 30% success rate plateau. Ovarian rejuvenation therapies using women's own blood are helping previously menopausal patients conceive with their own eggs, while 3D-printed artificial ovaries show promise in animal trials. From on-demand male birth control pills to AI-powered fertility treatments, 2026 represents a watershed moment when experimental technologies become clinical reality; finally offering reproductive choices and hope to millions who have been waiting for breakthrough innovations in family planning.